Positive Ellex 2RT Data Demonstrates Efficacy In Treatment Of Early AMD
Adelaide, Australia, 3 May 2011 - Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic technology, today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RTT) for the treatment of Early Age-Related Macular Degeneration (AMD).